Entresto 24 MG-26 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26F6SJ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,647
Award facts
- Contract value 100% obligated
- $27,646.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $27,646.82 to Amerisourcebergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). The contract was awarded on January 20, 2026, with an ultimate completion date of January 21, 2026, and was performed at the awardee's facility in Conshohocken, Pennsylvania. This non-set-aside delivery order was competitively awarded under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle extending through December 2026. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran healthcare systems.
Entresto, a combination medication containing sacubitril and valsartan, is a heart failure treatment commonly prescribed within military and Veterans Affairs healthcare systems. The delivery order reflects DLA's ongoing pharmaceutical procurement operations to maintain adequate medical supply inventories for military treatment facilities and other federal healthcare programs. Amerisourcebergen's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains on a competitive basis, positioning the company as a primary vendor for the Defense Logistics Agency's critical medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F6SJ5?
SPE2DR26F6SJ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F6SJ5 worth?
The government has obligated $27,647 on SPE2DR26F6SJ5.
Is contract SPE2DR26F6SJ5 an order under another contract?
Yes. SPE2DR26F6SJ5 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SJ5 competed?
The extent of competition for SPE2DR26F6SJ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award